Probiotics in clinical practice: A critical review of the evidence

Nutrition Research

Volumn 21, Issue 1-2, 2001, Pages 343-353

  McNaught, C E ^a   MacFie, J ^a,b  

^a SCARBOROUGH HOSPITAL   (United Kingdom)

^b Fax: 01723 354031 ^*  (United Kingdom)

Author keywords

Diarrhoea; Inflammatory Bowel Disease; Lactobacillus; Lipid metabolism; Probiotics; Surgical prophylaxis

Indexed keywords

PROBIOTIC AGENT;

CLINICAL PRACTICE; CLINICAL TRIAL; DIARRHEA; DIETARY INTAKE; DRUG INDICATION; DRUG RESEARCH; ENTERITIS; EVIDENCE BASED MEDICINE; HOST PARASITE INTERACTION; HUMAN; INTENSIVE CARE; INTESTINE FLORA; LACTOBACILLUS; LIPID METABOLISM; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW;

LACTOBACILLUS;

EID: 0035105801     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0271-5317(00)00286-4     Document Type: Review

References (64)

1. The control and consequences of bacterial fermentation in the human colon
2. Probiotics in man and animals
3. Probiotics, prebiotics and synbiotics: Approaches for modulating the microbial ecology of the gut
4. Clinical uses of probiotics for stabilizing the gut mucosal barrier: Successful strains and future challenges
5. Lactobacillus acidophilus LA1 binds to cultured human intestinal cells and inhibits cell attachment and cell invasion by enterovirulent bacteria
6. Lactobacillus GG-A human probiotic strain with thorough clinical documentation
7. Administration of different Lactobacillus strians in fermented oatmeal soup: In vivo colonisation of human intestinal mucosa and effect on the indigenous flora
8. A mannose specific adherence mechanism in Lactobacillus plantarum conferring binding to the human colonic cell line HT-29
9. Purification and characterisation of the Lactobacillus acidophilus bacteriocin lactacin B
10. Purification and characterisation of a bacteriocin produced by Lactobacillus acidophilus IBB 801
11. Antimicrobial substance from a human Lactobacillus strain
12. Immunological effects of yoghurt
13. The mucosal immune system: From fundamental concepts to vaccine development
14. Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake
15. Enhancement of natural immune function by dietary consumption of Bifidobacteria lactis (HN019)
16. Enhancement of the circulating antibody secreting cell response in human diarrhoea by a human Lactobacillus strain
17. Viable versus inactivated Lactobacillus strain GG in acute rotavirus diarrhoea
18. Production of human tumour necrosis factor alpha, Interleukin-6 and Interleukin-10 is induced by lactic acid bacteria
19. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus
20. Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhoea
21. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhoea: A multicenter European trial
22. A human Lactobacillus strain (Lactobacillus Casei strain GG) promotes recovery from acute diarrhoea in children
23. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis
24. A placebo-controlled trial of Lactobacillus GG to prevent diarrhoea in undernourished Peruvian children
25. Prevention and treatment of traveller's diarrhoea
26. Prevention of traveller's diarrhoea by Lactobacillus GG
27. Efficacy of Lactobacillus GG as a diarrhoeal preventive in travellers
28. Lactobacilli to prevent travellers diarrhoea?
29. Lactobacillus prophylaxis for diarrhoea due to enterotoxigenic Escherichia coli
30. Prophylactic efficacy of Lactobacilli on travellers diarrhoea
31. Increased risk of diarrhoea caused by Clostridium difficile in elderly patients receiving cefotaxime
32. Symptomatic relapse after oral vancomycin therapy of antibiotic associated pseudomembranous colitis
33. Prophylaxis against ampicillin associated diarrhoea with a Lactobacillus preparation
34. A double-blind placebo controlled study of the efficacy of Lactinex in the prophylaxis of amoxicillin-induced diarrhoea
35. Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea
36. Lactobacillus GG in the prevention of antibiotic associated diarrhoea in children
37. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG
38. Prevention of antibiotic associated diarrhoea by Saccharomyces boulardii: A prospective study
39. Prevention of β lactam associated diarrhoea by Saccharomyces boulardii compared with placebo
40. The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic related diarrhoea in elderly patients
41. Inflammatory bowel disease: Etiology and pathogenesis
42. Genes, bacteria and T cells: Ingredients for inflammatory bowel disease
43. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum
44. Controlled trial of metronidazole treatment for prevention of Crohn's disease after ileal resection
45. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in the excluded ileum
46. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats
47. Lactobacillus species prevents collitis in interleukin 10 gene deficient mice
48. Double blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis
49. Non pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis; a randomised trial
50. Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG
51. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis; a double blind placebo controlled trial
52. Helsinki Heart Study: Primary prevention trial with gemfibrozil in middle-aged men with dyslipidaemia. Safety of treatment changes in risk factors and incidence of coronary heart disease
53. Studies of a surfactant and cholesterolemia in the Maasai
54. Hypocholesterolaemic effect of a new fermented milk product in healthy middle aged men
55. Long-term (6 months) effect of a new fermented milk product on the level of plasma lipoproteins-a placebo controlled and double blind study
56. Effect of administration of fermented milk containing whey protein concentrate to rats and healthy men on serum lipids and blood pressure
57. Decrease in fibrinogen and LDL cholesterol levels upon supplementation of diet with Lactobacillus plantarum in subjects with moderately elevated cholesterol
58. Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases
59. Microbiology of bacterial translocation in humans
60. Gut barrier function and the surgeon
61. Nutrition and the gut mucosal barrier
62. The effect of probiotics on septic morbidity and mortality in critically ill patients